Treatment-Resistant Depression: When First-Line Treatment Isn't Working

If you have taken antidepressants and still feel depressed, you are not imagining it, and you are not alone. Treatment-resistant depression (TRD) — sometimes called refractory depression — is a recognized form of major depressive disorder that has not responded adequately to at least two different antidepressant medications, each taken at an adequate dose for an adequate length of time (typically six to eight weeks). The Cleveland Clinic defines it the same way, and a 2023 international consensus paper published in the Annals of General Psychiatry converged on this two-trial threshold as the working definition.

That definition has an important detail buried in it: each medication trial has to have been adequate. A few weeks at a low starter dose, or a prescription you stopped early because of side effects, does not meet the bar — even if it didn't help. This is why a careful look back at your treatment history is the first step, not the last.

TRD is common. According to Johns Hopkins Medicine, it affects roughly 30% of people diagnosed with major depressive disorder. It is also treatable. Recovery often takes a more systematic, stepped approach — but "we haven't found the right plan yet" is a very different statement than "nothing will work."

Not sure where your symptoms stand right now? You can take our free, confidential depression self-check to help organize what you're experiencing before an appointment.

Two patterns deserve special attention because they are so frequently misread as treatment resistance.

Atypical depression is a recognized specifier of major depressive disorder. Its defining feature is mood reactivity — your mood can lift in response to positive events — alongside two or more of the following: sleeping too much (hypersomnia), increased appetite or weight gain, a heavy "leaden paralysis" in the arms and legs, and a long-standing sensitivity to interpersonal rejection. Because someone with atypical depression can still laugh at a good moment, it is often dismissed as "not real depression" or treated with a plan better suited to a different subtype. It is not inherently harder to treat — it is just more often misidentified, which is exactly why a careful diagnostic re-assessment can change everything.

"High-functioning depression" is not a formal DSM-5 diagnosis; it is a descriptive term for people who keep performing — holding down a job, raising kids, showing up — while privately feeling flat, exhausted, joyless, or numb. Because the outside looks fine, these symptoms are frequently under-reported and under-treated for years. The same masking pattern shows up with anxiety; if that resonates, our page on high-functioning anxiety explores the overlap in more depth. The danger with both patterns is the same: when symptoms go unspoken, they also go untreated, and the depression that finally gets attention can look "resistant" simply because it was never addressed head-on.

For some people with treatment-resistant depression, the next step is a more advanced, specialized treatment. These are real, evidence-based options — and we want you to know about all of them, even the ones we do not provide ourselves.

• Transcranial Magnetic Stimulation (TMS) is a non-invasive treatment that uses magnetic pulses to stimulate areas of the brain involved in mood. It is performed in an outpatient setting, requires no anesthesia, and is an established option for medication-resistant depression, as described by the NIMH's overview of brain stimulation therapies.
• Esketamine (Spravato) is an FDA-approved nasal-spray medication for treatment-resistant depression. Because of its monitoring requirements, it can only be given in a REMS-certified healthcare setting under direct supervision — it is not a take-home prescription.
• Electroconvulsive therapy (ECT) remains one of the most effective treatments for severe, treatment-resistant depression and is delivered by specialized programs.

DMHBH does not provide TMS, esketamine/ketamine, or ECT in-house. These are specialized treatments delivered by dedicated programs, and people in Charlotte and DeSoto Counties typically access them in larger metro areas such as Sarasota, Fort Myers, or Tampa. If one of these advanced options turns out to be the right next step for you, we can help point you in the right direction while continuing to manage your medication and therapy right here — so you are not left to figure it out entirely on your own. (Specialized modalities such as DBT, ERP, and schema therapy are likewise available through specialized providers.)